ProQR Therapeutics N.V. buy Chardan Capital
Start price
08.11.23
/
50%
€1.27
Target price
08.11.24
€1.87
Performance (%)
170.93%
End price
09.11.24
€3.43
Summary
This prediction ended on 09.11.24 with a price of €3.43. The BUY prediction by Chardan_Capital for ProQR Therapeutics N.V. saw massive gains of 170.93%. Chardan_Capital has a follow-up prediction for ProQR Therapeutics N.V. where he still thinks ProQR Therapeutics N.V. is a Buy. Chardan_Capital has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| ProQR Therapeutics N.V. | 13.091% | 13.091% | -25.324% |
| iShares Core DAX® | 0.734% | 1.458% | 17.980% |
| iShares Nasdaq 100 | -2.686% | -0.146% | 3.810% |
| iShares Nikkei 225® | -2.261% | -2.729% | 11.679% |
| iShares S&P 500 | -1.346% | 0.467% | 1.970% |
Comments by Chardan_Capital for this prediction
In the thread ProQR Therapeutics N.V. diskutieren
ProQR Therapeutics (NASDAQ: PRQR) was upgraded by analysts at Chardan Capital from a "neutral" rating to a "buy" rating. They now have a $2.00 price target on the stock.
Ratings data for PRQR provided by MarketBeat
In the thread Trading ProQR Therapeutics N.V.
Die von Chardan_Capital gewählte maximale Laufzeit wurde überschritten
Current prediction by Chardan_Capital for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.59
14.03.25
14.03.25
€3.69
14.03.26
14.03.26
28.61%
07:36
07:36
Stopped prediction by Chardan_Capital for ProQR Therapeutics N.V.
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€2.05
04.11.25
04.11.25
€3.48
04.11.26
04.11.26
-5.28%
07:36
07:36
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.80
08.08.25
08.08.25
€3.43
08.08.26
08.08.26
14.02%
07:36
07:36
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€3.10
12.12.24
12.12.24
€3.81
12.12.25
12.12.25
-37.48%
13.12.25
13.12.25
ProQR Therapeutics N.V.
Start price
Target price
Perf. (%)
€1.86
10.05.24
10.05.24
€2.32
10.05.25
10.05.25
-20.11%
11.05.25
11.05.25